Please login to the form below

Not currently logged in
Email:
Password:

Hemlibra

This page shows the latest Hemlibra news and features for those working in and with pharma, biotech and healthcare.

Ocrevus surge keeps Roche smiling in Q3

Ocrevus surge keeps Roche smiling in Q3

Another bright spot for Roche was strong early uptake of new haemophilia A therapy Hemlibra (emicizumab), a blockbuster-in-waiting which added CHF 113m to the pot from its use in

Latest news

  • Roche gets wider approval for haemophilia drug Hemlibra Roche gets wider approval for haemophilia drug Hemlibra

    Hemlibra (eculizumab) was cleared for use in patients with inhibitors last year, and is now the only FDA-approved drug for both sets of patients. ... Roche says that Hemlibra is the first drug to show an improvement over standard haemophilia A treatment,

  • Bayer roll-out of haemophilia drug Jivi gathers pace Bayer roll-out of haemophilia drug Jivi gathers pace

    Meanwhile, the imminent regulatory verdict in the US for Roche’s Hemlibra (emicizumab) in haemophilia A patients without inhibitors to factor VIII, which could dramatically broaden the number of patients eligible

  • Roche highlights Hemlibra data as key FDA date approaches Roche highlights Hemlibra data as key FDA date approaches

    It also says 98% of patients in this trial preferred Hemlibra over factor VIII prophylaxis. ... Horning added: “Given the challenges many people face managing their haemophilia, we believe Hemlibra could make a meaningful difference.”.

  • Immunology keeps Shire figures solid as Takeda takeover nears Immunology keeps Shire figures solid as Takeda takeover nears

    However, Shire’s drugs for haemophilia patients with inhibitors such as Feiba came under competitive pressure from the likes of Roche’s recently-approved Hemlibra (emicizumab), falling 6%.

  • NHS England says yes to Roche's Hemlibra NHS England says yes to Roche's Hemlibra

    But stalls on funding for Actelion's Uptravi. Roche’s new haemophilia A treatment Hemlibra has gained a valuable market access approval from NHS England. ... The date that patients will be able to access Hemlibra is expected to be announced shortly.

More from news
Approximately 10 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics